Aptorum Group Ltd reported an extension of its merger agreement with DiamiR Biosciences Corp. until June 30, 2026, originally set for December 31, 2025. This follows a merger plan established on July 14, 2025, where Aptorum will acquire DiamiR, with DiamiR becoming a wholly owned subsidiary.